Table 3.
Overall (n = 2099) | Men (n = 974) | Women (n = 1125) | p value | |
---|---|---|---|---|
Oral antibiotics | ||||
(n = 2013) | (n = 935) | (n = 1078) | 0.07 | |
No | 1645 (81.7) | 776 (83.0) | 869 (80.6) | |
Continuous | 77 (3.8) | 26 (2.8) | 51 (4.7) | |
Cyclic | 291 (14.5) | 133 (14.2) | 158 (14.7) | |
Inhaled antibiotics | ||||
(n = 1954) | (n = 911) | (n = 1043) | 0.58 | |
No | 1586 (81.2) | 731 (80.2) | 855 (82.0) | |
Continuous | 273 (14.0) | 132 (14.5) | 141 (13.5) | |
Periodic | 95 (4.9) | 48 (5.3) | 47 (4.5) | |
Inhaled bronchodilators | ||||
(n = 1986) | (n = 919) | (n = 1067) | 0.08 | |
n (%) | 1519 (76.5) | 720 (78.3) | 799 (74.9) | |
Inhaled corticosteroids | ||||
(n = 1961) | (n = 909) | (n = 1052) | 0.55 | |
n (%) | 1336 (68.1) | 626 (68.9) | 710 (67.5) |